Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line

Veterinary Research

Volumn 36, Issue 2, 2005, Pages 257-262

  Lankveld, Daniëlle P K ^a   Bull, Sarah ^a   Van Dijk, Paul ^a   Fink Gremmels, Johanna ^a   Hellebrekers, Ludo J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cytokine; eCAS; Equine endotoxaemia; Ketamine

Indexed keywords

INTERLEUKIN 6; KETAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; ENDOTOXEMIA; HORSE; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANESTHETICS, DISSOCIATIVE; ANIMALS; CELL LINE; HORSES; HUMANS; INTERLEUKIN-6; KETAMINE; LIPOPOLYSACCHARIDES; MACROPHAGES; TUMOR NECROSIS FACTOR-ALPHA;

EQUIDAE;

EID: 14844363424     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: 10.1051/vetres:2004061     Document Type: Article

References (21)

1. Barton M.H., Collatos C., Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease, J. Vet. Intern. Med. 13 (1999) 457-464.
2. Bertoni G., Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK (15), J. Immunol. Methods 160 (1993) 267-271.
3. Bull S., Langezaal I., Clothier R., Coecke S., A genetically engineered cell-based system for detecting metabolism-mediated toxicity, Altern. Lab. Anim. 29 (2001) 703-716.
4. Giraud O., Seince P.F., Rolland C., Lecon-Malas V., Desmonts J.M., Aubier M., Dehoux M., Halothane reduces the early lipopolysaccharide-induced lung inflammation in mechanically ventilated rats, Am. J. Respir. Crit. Care Med. 162 (2000) 2278-2286.
5. Kawasaki T., Ogata M., Kawasaki C., Ogata J., Inoue Y., Shigematsu A., Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro, Anesth. Analg. 89 (1999) 665-669.
6. Kohrs R., Durieux M.E., Ketamine: teaching an old drug new tricks, Anesth. Analg. 87 (1998) 1186-1193.
7. Larsen B., Hoff G., Wilhelm W., Buchinger H., Wanner G.A., Bauer M., Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood, Anesthesiology 89 (1998) 1218-1227.
8. Morris D.D., Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis, J. Vet. Intern. Med. 5 (1991) 167-181.
9. Morris D.D., Crowe N., Moore J.N., Moldawer L.L., Endotoxin-induced production of interleukin 6 by equine peritoneal macrophages in vitro, Am. J. Vet. Res. 53 (1992) 1298-1301.
10. Mosman T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
11. Muir W.W., Sams R., Effects of ketamine infusion on halothane minimal alveolar concentration in horses, Am. J. Vet. Res. 53 (1992) 1802-1806.
12. Muir W.W., Skarda R.T., Milne D.W., Evaluation of xylazine and ketamine hydrochloride for anesthesia in horses, Am. J. Vet. Res. 38 (1977) 195-201.
13. Okada H., Detection of Interleukin-1 and Interleukin-6 on cryopreserved bovine mammary epithelial cells in vitro, J. Vet. Med. Sci. 59 (1997) 503-507.
14. Reves J.G., Glass P.S.A., Lubarsky D.A., Nonbarbiturate intravenous anesthetics, in: Miller R.D. (Ed.), Anesthesia, Churchill Livingstone, New York, 2000, pp. 228-272.
15. Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A., Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice, Anesthesiology 80 (1994) 402-408.
16. Taniguchi T., Shibata K., Yamamoto K., Ketamine inhibits endotoxin-induced shock in rats, Anesthesiology 95 (2001) 928-932.
17. Wang S., Yan L., Wesley R.A., Danner R.L., Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP, J. Biol. Chem. 272 (1997) 5959-5965.
18. Waterman A.E., Robertson S.A., Lane J.G., Pharmacokinetics of intravenously administered ketamine in the horse, Res. Vet. Sci. 42 (1987) 162-166.
19. Weigand M.A., Schmidt H., Zhao Q., Plaschke K., Martin E., Bardenheuer H.J., Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro, Anesth. Analg. 90 (2000) 206-212.
20. Werners A.H., Bull S., Fink-Gremmels J., Bryant C.E., Generation and characterization of an equine macrophage cell line (e-CAS cells) derived from equine bone marrow cells, Vet. Immunol. Immunopathol. 97 (2004) 65-76.
21. Yu Y., Zhou Z., Xy J., Liu Z., Wang Y., Ketamine reduces NF-kappa-B activation and TNF-alpha production in rat mononuclear cells induced by lipopolysaccharide in vitro, Ann. Clin. Lab. Sci. 32 (2002) 292-298.